https://www.bizcommunity.com/196/398.html South Africa Pharmaceuticals news 15 Pharmaceuticals news - South Africa https://www.bizcommunity.com/res/img/logo.gif https://www.bizcommunity.com/196/398.html en-us Mon, 21 Sep 2026 22:08:15 +0200 https://www.bizcommunity.com/article/springbok-bafana-bafana-stars-tackle-obesity-in-new-novo-nordisk-campaign-742882a Pharmaceutical company Novo Nordisk has teamed up with South African sports stars in a new campaign to tackle rising obesity among men in the country. 1-271722 Tue, 15 Sep 2026 08:38:00 +0200 Bizcommunity Pharmaceuticals South Africa https://www.bizcommunity.com/article/bayer-faces-a-lawsuit-over-unplanned-pregnancies-linked-to-defective-birth-control-308818a A law firm has indicated that more than 300 women have initiated a lawsuit over Bayer’s recalled batch of Yaz Plus contraceptives in 2024. 1-271543 Tue, 08 Sep 2026 11:00:00 +0200 Bizcommunity Pharmaceuticals South Africa https://www.bizcommunity.com/article/aspen-to-make-sas-hunger-for-weight-loss-drugs-its-bread-and-butter-742682a Aspen Pharmacare forecast strong double-digit earnings growth for fiscal 2027, as the South African drugmaker bet on a sharp recovery in its manufacturing business and the global rollout of its generic weight-loss medicines. 1-271422 Thu, 03 Sep 2026 07:10:00 +0200 Bizcommunity Pharmaceuticals South Africa https://www.bizcommunity.com/article/gummies-fizzies-and-easy-formats-sa-vitamins-and-supplements-become-easier-to-consume-967744a The South African vitamins and supplements market is becoming more convenient, flavour-led and format-driven, as brands compete to make daily wellness easier to fit into consumers’ routines. 1-270984 Thu, 20 Aug 2026 11:23:00 +0200 Bizcommunity Pharmaceuticals South Africa https://www.bizcommunity.com/article/sahpra-recalls-arya-pharmas-high-blood-pressure-meds-enalapril-078285a Arya Pharma has recalled four batches of its high blood pressure medication, Enalapril 10mg Arya. The South African Health Products Regulatory Authority (Sahpra) initiated the recall after post-marketing surveillance inspections identified results that failed to meet specifications. 1-270847 Mon, 17 Aug 2026 10:47:00 +0200 Bizcommunity Pharmaceuticals South Africa https://www.bizcommunity.com/article/aspen-gets-merck-licensing-agreement-for-experimental-hiv-pill-078055a South African pharmaceutical company Aspen Pharmacare is one of seven generic drug manufacturers licensed to produce and sell lower-cost versions of Merck’s experimental once-monthly oral HIV pill in 129 low- and lower-middle-income countries. 1-270187 Fri, 24 Jul 2026 14:06:00 +0200 Bizcommunity Pharmaceuticals South Africa https://www.bizcommunity.com/article/novo-nordisk-v-idexis-whats-in-a-name-or-in-this-case-a-compounded-medicine-634621a The legal battle between Novo Nordisk and Pretoria-based pharmacy group iDexis could reshape South Africa’s compounding medicine landscape. 1-270161 Fri, 24 Jul 2026 09:18:00 +0200 Bizcommunity Pharmaceuticals South Africa https://www.bizcommunity.com/article/novos-expired-semaglutide-patent-fires-up-weight-loss-drug-market-290577a The weight-loss drug market in South Africa is heating up as several generic pharmaceutical companies seek to capitalise on Novo Nordisk’s expired semaglutide patent. 1-270080 Wed, 22 Jul 2026 08:59:00 +0200 Bizcommunity Pharmaceuticals South Africa https://www.bizcommunity.com/article/novo-nordisk-enters-the-chat-with-launch-of-cheaper-ozempic-copy-953724a In an effort to expand patient access, Novo Nordisk has partnered with healthcare company Acino to launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa later this month. 1-269994 Mon, 20 Jul 2026 09:24:00 +0200 Bizcommunity Pharmaceuticals South Africa https://www.bizcommunity.com/article/idexis-appeals-high-courts-ruling-on-novo-nordisk-weight-loss-drugs-286477a Pretoria-based pharmacy group iDexis said it had applied to appeal a court judgment that curbed its production of compounded weight-loss medicines, disputing allegations about product safety and regulatory compliance. 1-269880 Wed, 15 Jul 2026 09:54:00 +0200 Bizcommunity Pharmaceuticals South Africa